Press Releases

Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations

Posted on August 16, 2016

“We are delighted to welcome Aetna to Carmot’s Board and Elena to our senior management team as the company advances its growing metabolic disease pipeline toward the clinic,” said CEO Stig Hansen. more

 

Carmot Therapeutics Enters into Drug Discovery Collaboration with Genentech

Posted on July 6, 2016

Carmot Therapeutics announced today that it has entered into a drug discovery collaboration and license agreement with Genentech, a member of the Roche Group. more

 

Carmot Therapeutics Extends Drug Discovery Collaboration with Amgen

Posted on Feb 16, 2016

Carmot Therapeutics announced today  it has extended the research collaboration and license agreement with Amgen Inc. (Thousand Oaks, Calif.) that was first announced in 2014. more

 

Carmot Therapeutics Strengthens Executive Management Team

Posted on Jun 21, 2014

Carmot Therapeutics announced today that Dave Jobes, PhD, has joined the company as vice president of business development. more

 

Carmot enters into collaboration with Amgen

Posted on Jan 14, 2014

Carmot Therapeutics enters into Drug Discovery Collaboration with Amgen. more

 

Carmot wins NCI SBIR Phase II award

Posted on Oct 7, 2013

Carmot wins National Cancer Institute SBIR Phase II award to discover anticancer drugs. more

 

“Biased agonism” for Class-B GPCRs award

Posted on Oct 16, 2012

Carmot wins National Institute of Diabetes and Digestive and Kidney Diseases award to study drug leads with “biased agonism” for Class-B GPCRs. more

 

Carmot Therapeutics wins NSF SBIR Phase II award

Posted on Dec 8, 2011

Carmot Therapeutics wins NSF SBIR Phase II award to discover novel anticancer leads and further develop its proprietary technology, Chemotype Evolution. more

 

Diabetes and Digestive and Kidney Diseases award

Posted on Jul 11, 2011

Carmot wins National Institute of Diabetes and Digestive and Kidney Diseases award to discover drugs for metabolic diseases.  more